Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
55.74
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Smart Money Is Betting Big In MRNA Options
↗
November 08, 2024
Via
Benzinga
2 Biotech Stocks You Can Buy Hand Over Fist This Month
↗
November 08, 2024
Both stocks have made significant breakthroughs.
Via
The Motley Fool
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
November 08, 2024
Via
ACCESSWIRE
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
↗
November 07, 2024
Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda.
Via
Benzinga
Topics
Government
Moderna (MRNA) Q3 2024 Earnings Call Transcript
↗
November 07, 2024
MRNA earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Moderna Q3 Revenue Beats On Updated COVID-19 Vaccine, Slashes Expenses For 2024
↗
November 07, 2024
Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.
Via
Benzinga
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 07, 2024
Via
ACCESSWIRE
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
↗
November 04, 2024
Via
Benzinga
In-Depth Examination Of 15 Analyst Recommendations For Moderna
↗
November 04, 2024
Via
Benzinga
Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?
↗
November 07, 2024
The company reported just $10 million in sales of its RSV vaccine, mResvia, widely missing expectations.
Via
Investor's Business Daily
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
↗
November 07, 2024
Via
Benzinga
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped
↗
November 06, 2024
On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade
Via
Benzinga
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
↗
November 06, 2024
Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease.
Via
Benzinga
Topics
Government
These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over
↗
November 06, 2024
Perhaps this list is a good place to start bargain-hunting.
Via
The Motley Fool
Topics
Stocks
Moderna to Present at Upcoming Conferences in November 2024
October 31, 2024
Via
ACCESSWIRE
Behind the Scenes of Moderna's Latest Options Trends
↗
October 29, 2024
Via
Benzinga
Moderna Unusual Options Activity For October 22
↗
October 22, 2024
Via
Benzinga
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
↗
November 06, 2024
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
November 05, 2024
Via
Benzinga
2 Dividend Stocks to Buy for a Lifetime of Passive Income
↗
November 02, 2024
These are the kinds of stocks that can allow investors to sleep easy at night.
Via
The Motley Fool
These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could The Trend Continue If Harris Wins 2024 Election?
↗
October 31, 2024
A look at the top 10 performing S&P 500 stocks in 2021 could point to trends to watch if Kamala Harris wins the 2024 election.
Via
Benzinga
Topics
Stocks
A Closer Look at Moderna's Options Market Dynamics
↗
October 21, 2024
Via
Benzinga
Why Is Moderna Stock Trading Higher On Monday?
↗
October 28, 2024
Merck and Moderna initiate Phase 3 trial of mRNA-4157 (V940) with Keytruda as adjuvant for NSCLC patients, marking progress in individualized cancer therapies.
Via
Benzinga
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
October 28, 2024
From
Merck & Co., Inc.
Via
Business Wire
Large-Cap Stocks In Trouble - Sunday, Oct. 27
↗
October 27, 2024
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Moderna Named a Top Employer by Science for Tenth Consecutive Year
October 24, 2024
Via
ACCESSWIRE
How Bad Is This News for Novavax?
↗
October 19, 2024
Novavax stock fell 20% in one trading session on the news.
Via
The Motley Fool
Large-Cap Stocks In Trouble - Saturday, Oct. 19
↗
October 19, 2024
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.
Via
Talk Markets
Benzinga Bulls And Bears: Apple, Tesla, Netflix, Oklo — And Dogecoin, Meme Coins Outpace Corporate Giants
↗
October 19, 2024
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Via
Benzinga
Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season
↗
October 18, 2024
Goldman Sachs identified 20 stocks with high short interest that could be primed for a short squeeze. Hint: A pet retailer tops the chart.
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
